Leading Innovation in Genetically Designed Vaccines

Our talented, passionate and dedicated teams focus on the Discovery of breakthrough technologies, the Design of genetic vaccines, the product Development and the Deployment of life-saving vaccines through our global manufacturing or Distribution network.

DNA and mRNA COVID-19

Clinical development of BioNet COVID-19 DNA candidate vaccines are conducted in Australia by Technovalia and partners.

BioNet has been manufacturing a mRNA COVID-19 vaccine developed by Chulalongkorn University and the University of Pennsylvania.

BioNet is the lead partner of a vaccine development consortium composed of US and Thai universities and the International Vaccine Institute to develop a pancoronavirus mRNA vaccine with the support from CEPI.